CICALA, MICHELE
 Distribuzione geografica
Continente #
AS - Asia 8.273
NA - Nord America 4.002
EU - Europa 1.555
SA - Sud America 378
AF - Africa 80
Continente sconosciuto - Info sul continente non disponibili 72
OC - Oceania 32
AN - Antartide 1
Totale 14.393
Nazione #
SG - Singapore 6.023
US - Stati Uniti d'America 3.825
CN - Cina 1.183
IT - Italia 719
HK - Hong Kong 527
GB - Regno Unito 256
BR - Brasile 253
FR - Francia 191
VN - Vietnam 176
DE - Germania 123
IN - India 90
CA - Canada 83
BD - Bangladesh 70
MX - Messico 59
AR - Argentina 45
NL - Olanda 43
FI - Finlandia 33
AU - Australia 31
JP - Giappone 30
ZA - Sudafrica 28
ID - Indonesia 27
ES - Italia 23
CZ - Repubblica Ceca 20
TR - Turchia 20
CO - Colombia 19
UA - Ucraina 19
PK - Pakistan 18
RU - Federazione Russa 18
PL - Polonia 17
SE - Svezia 16
EC - Ecuador 14
IQ - Iraq 14
VE - Venezuela 14
AT - Austria 11
BE - Belgio 11
MY - Malesia 11
PH - Filippine 10
CL - Cile 8
PE - Perù 8
PY - Paraguay 8
SA - Arabia Saudita 8
EG - Egitto 7
MA - Marocco 7
AE - Emirati Arabi Uniti 6
BO - Bolivia 6
ET - Etiopia 6
GR - Grecia 6
MD - Moldavia 6
NP - Nepal 6
TH - Thailandia 6
UZ - Uzbekistan 6
CH - Svizzera 5
CR - Costa Rica 5
IR - Iran 5
JM - Giamaica 5
JO - Giordania 5
KZ - Kazakistan 5
RO - Romania 5
TN - Tunisia 5
AZ - Azerbaigian 4
HU - Ungheria 4
DO - Repubblica Dominicana 3
DZ - Algeria 3
GT - Guatemala 3
HN - Honduras 3
IL - Israele 3
KE - Kenya 3
KG - Kirghizistan 3
LU - Lussemburgo 3
OM - Oman 3
PR - Porto Rico 3
RS - Serbia 3
SN - Senegal 3
UY - Uruguay 3
AL - Albania 2
AM - Armenia 2
AO - Angola 2
BG - Bulgaria 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
DM - Dominica 2
GA - Gabon 2
IE - Irlanda 2
KH - Cambogia 2
LC - Santa Lucia 2
LY - Libia 2
NG - Nigeria 2
PT - Portogallo 2
SI - Slovenia 2
AF - Afghanistan, Repubblica islamica di 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BS - Bahamas 1
BT - Bhutan 1
BZ - Belize 1
CG - Congo 1
CU - Cuba 1
CW - ???statistics.table.value.countryCode.CW??? 1
Totale 14.293
Città #
San Jose 1.173
Singapore 767
Ashburn 742
Hong Kong 514
Rome 502
Hefei 371
Beijing 320
Council Bluffs 281
Boardman 218
London 217
Columbus 197
Lauterbourg 167
Dallas 145
Shanghai 128
Santa Clara 101
Ho Chi Minh City 78
Los Angeles 72
New York 57
Munich 49
Phoenix 42
San Francisco 42
West Jordan 40
Mexico City 39
Washington 35
Pune 34
Hanoi 30
Seattle 29
Amsterdam 27
São Paulo 27
Turku 23
Toronto 21
Brooklyn 18
Burlington 18
Sona 18
Buffalo 16
Chicago 16
Orem 16
Tokyo 16
Frankfurt am Main 14
Montreal 14
Warsaw 14
Chennai 13
Boston 12
Brno 12
Charlotte 12
Las Vegas 12
Melbourne 12
Milan 11
Helsinki 10
Rio de Janeiro 10
Stockholm 10
Brussels 9
Canberra 9
Johannesburg 9
Paris 9
Atlanta 8
Buenos Aires 8
Bogotá 7
Chengdu 7
Curitiba 7
Guangzhou 7
Haiphong 7
Manchester 7
Olomouc 7
Asti 6
Athens 6
Dhaka 6
Guarulhos 6
Naples 6
Pastorano 6
Quito 6
Secaucus 6
Surabaya 6
Sydney 6
Amman 5
Bari 5
Bologna 5
Catania 5
Da Nang 5
Denver 5
Hanover 5
Kingston 5
Kuala Lumpur 5
Lahore 5
Markham 5
Mumbai 5
Narni 5
San Juan 5
Staten Island 5
Vienna 5
Addis Ababa 4
Baghdad 4
Bangkok 4
Berlin 4
Cape Town 4
Caracas 4
Cleveland 4
Dubai 4
Hamburg 4
Hangzhou 4
Totale 7.043
Nome #
Constipation-Predominant Irritable Bowel Syndrome (IBS-C): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms 249
Colonic Epithelial Permeability to Ions Is Restored after Vedolizumab Treatment and May Predict Clinical Response in Inflammatory Bowel Disease Patients 243
Dilated intercellular spaces of esophageal epithelium in nonerosive reflux disease patients with physiological esophageal acid exposure 239
Early impairment of food intake in patients newly diagnosed with cancer 237
Effect of hypothermia on human colonic smooth muscle contractility 237
Novel impedance-pH parameters are associated with proton pump inhibitor response in patients with inconclusive diagnosis of gastro-oesophageal reflux disease according to Lyon Consensus 231
Anti-tumor necrosis factor-alpha reverts growth hormone resistance associated with inflammatory bowel disease 229
DECREASED NUMBER OF ACTIVATED MACROPHAGES IN GALLBLADDER MUSCLE LAYER OF CHOLESTEROL GALLSTONES PATIENTS FOLLOWUING URSODEOXYCHOLIC ACID 223
EFFECTS OF THERMAL COOLING ON HUMAN COLONIC SMOOTH MUSCLE CONTRACTILITY 221
Effect of oesophagitis on proximal extent of gastro-oesophageal reflux. 221
Impaired Human Colonic Contractility and Toll-Like Receptor 4 (TLR4) Expression in Uncomplicated Diverticular Disease 218
Clinical impact of proton pump inhibitor response and dependence 212
Effect of the gatekeeper reflux repair system on intra-esophageal distribution of acid reflux in gastroesophageal reflux disease patients: Relation with typical symptoms 212
IMPAIRED HUMAN COLONIC CONTRACTILITY AND TOLL-LIKE RECEPTOR 4 (TLR4) EXPRESSION IN UNCOMPLICATED DIVERTICULAR DISEASE 210
Impairment of GH/IGF-1 Axis in the liver of patients with hcv-related chronic hepatitis 209
Correlation between reflux burden, peristaltic function, and mucosal integrity in GERD patients 198
Association between dietary habits and fecal microbiota composition in irritable bowel syndrome patients: A pilot study 167
Achalasia, from diagnosis to treatment 148
Activated muscularis macrophages contribute to muscle cell dysfunction in cholesterol gallstone patients 148
Association between post-reflux swallow-induced peristaltic wave index and esophageal mucosal integrity in patients with GERD symptoms 142
Acid reflux episodes sensitize the esophagus to perception of weakly acidic and mixed reflux in non-erosive reflux disease patients 142
Chicago Classification v4.0 Stratifies Acid Burden and Abnormal Impedance-pH Variables Better Than Chicago Classification v3.0 Chicago Classification v4.0 and GERD 140
Wall Thickness Ratio—A New Magnetic Resonance Parameter—Is Associated With the Outcome of Biological Therapy in Patients With Ileal and Ileocolonic Crohn’s Disease 139
Effect of acute mucosal exposure to Lactobacillus rhamnosus GG on human colonic smooth muscle cells 137
Gut Microbiota and Related Electronic Multisensorial System Changes in Subjects With Symptomatic Uncomplicated Diverticular Disease Undergoing Rifaximin Therapy 135
Breathing training on lower esophageal sphincter as a complementary treatment of gastroesophageal reflux disease (GERD): a systematic review 134
Anxiety correlates with excessive air swallowing and PPI refractoriness in patients with concomitant symptoms of GERD and functional dyspepsia 133
Decreased number of activated macrophages in gallbladder muscle layer of cholesterol gallstone patients following ursodeoxycholic acid 130
Asymptomatic parasitic infection in a Crohn's disease patient on anti-TNFα therapy: an alert for our patients? 127
Antioxidant activity of Inulin and its role in the prevention of human colonic muscle cell impairment induced by Lipopolysaccharide mucosal exposure 126
Effect of Inulin on Proteome Changes Induced by Pathogenic Lipopolysaccharide in Human Colon 126
Gastrointestinal sensitivity and gastroesophageal reflux disease 126
Mathematical Modeling of Vedolizumab Treatment’s Effect on Microbiota and Intestinal Permeability in Inflammatory Bowel Disease Patients 122
Dynamic contrast enhanced magnetic resonance imaging of the terminal ileum: differentiation of activity of Crohn’s disease 121
Effect of hiatal hernia on proximal oesophageal acid clearance in gastro-oesophageal reflux disease patients 120
Effect of endoscopic augmentation of the lower oesophageal sphincter (Gatekeeper reflux repair system) on intraoesophageal dynamic characteristics of acid reflux 117
LPS AND RADIATION-INDUCED GUT PERMEABILITY DAMAGE: FOCUS ON THE POTENTIAL BENEFICIAL EFFECT OF GRAPE SEED EXTRACT 115
Esophageal disease: updated information on inflammation 112
Experimental evidence and mathematical modeling of thermal effects on human colonic smooth muscle contractility 108
Esophageal pH increments associated with post-reflux swallow-induced peristaltic waves show the occurrence and relevance of esophago-salivary reflex in clinical setting 106
Human colonic myogenic dysfunction induced by mucosal lipopolysaccharide translocation and oxidative stress 105
Gastroesophageal reflux disease: Update on inflammation and symptom perception 101
Impedance baseline and reflux perception in responder and non-responder non-erosive reflux disease patients 100
Gastro-esophageal reflux disease and Obesity, where is the link? 97
Dilated intercellular spaces and acid reflux at the distal and proximal oesophagus in patients with non-erosive gastro-oesophageal reflux disease 93
Mechanisms of action of prebiotics and their effects on gastro-intestinal disorders in adults 91
Impaired colonic contractility and intestinal permeability in symptomatic uncomplicated diverticular disease 90
Diarrhea predominant-irritable bowel syndrome (Ibs-d): Effects of different nutritional patterns on intestinal dysbiosis and symptoms 88
Chronic Gastrointestinal Disorders and miRNA-Associated Disease: An Up-to-Date 85
Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study 77
Esophageal chest pain resembles heartburn in reflux metrics and response to proton pump inhibitor therapy 76
Palmitic acid affects intestinal epithelial barrier integrity and permeability in vitro 76
Nutritional status and bioelectrical phase angle assessment in adult Crohn disease patients receiving anti-TNFα therapy 74
Ursodeoxycholic acid improves muscle contractility and inflammation in symptomatic gallbladders with cholesterol gallstones 74
Psychological distress in inflammatory bowel disease 73
Impedance-High Resolution Manometry Analysis of Patients With Nonerosive Reflux Disease 72
HCl-induced and ATP-dependent upregulation of TRPV1 receptor expression and cytokine production by human esophageal epithelial cells 72
Lactobacillus rhamnosus protects human colonic muscle from pathogen lipopolysaccharide-induced damage. 71
Patients With Definite and Inconclusive Evidence of Reflux According to Lyon Consensus Display Similar Motility and Esophagogastric Junction Characteristics 71
Prospective validation of reflux monitoring by impedance-pH in predicting PPI response in typical GERD 71
Immunohistochemical evaluation of pRb2/p130, VEGF, EZH2, p53, p16, p21(waf-1), p27, and PCNA in Barrett's esophagus 68
Platelet-activating factor and distinct chemokines are elevated in mucosal biopsies of erosive compared with non-erosive reflux disease patients and controls 66
A health technology-related cost description concerning italian IBD centres dealing with Crohn's disease results from SOLE study 65
The Results From Up-Front Esophageal Testing Predict Proton Pump Inhibitor Response in Patients With Chronic Cough 64
Natural Compounds with Antimicrobial Activities in Oral Candida Infections during Head and Neck Radiotherapy 63
Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough. 63
A SIGE-SINGEM-AIGO technical review on the clinical use of esophageal reflux monitoring 62
High Resolution Manometry Findings Do Not Predict Bolus Clearance of Saline Swallows in Patients With Non-Obstructive Dysphagia 62
Safety and tolerability of a novel oral nutritional supplement in healthy volunteers 62
Protective Role of Natural Compounds under Radiation-Induced Injury 60
Infliximab reverses growth hormone resistance associated with inflammatory bowel disease 60
Expression of GH/IGF-1 Axis Compounds in Moderate-Severe Crohn's Disease: Role of Mucosal Inflammation and Anti TNF-alpha Treatment 60
48-Hour Monitoring Significantly Increases Diagnostic Yield of Multichannel Intraluminal pH-Impedance in Non-Erosive Reflux Disease Patients 59
Intra-oesophageal distribution and perception of acid reflux in patients with non-erosive gastro-oesophageal reflux disease 58
Phylogenetic analysis of Prevotella copri from fecal and mucosal microbiota of IBS and IBD patients 57
Effect of spasmodil complex on bile flow. Double-blind controlled study 57
Complementary and alternative medicine in irritable bowel syndrome: a survey amongst italian gastroenterologists 57
Ursodeoxycholic acid therapy in gallbladder disease, a story not yet completed 57
Antro-pyloric contractile patterns and transpyloric flow after meal ingestion in humans 57
Ambulatory reflux monitoring for diagnosis of gastro-esophageal reflux disease: Update of the Porto consensus and recommendations from an international consensus group 57
Human Colonic Smooth Muscle Contractility Following Acute Thermal Cooling 57
Randomised clinical trial: mucosal protection combined with acid suppression in the treatment of non-erosive reflux disease - efficacy of Esoxx, a hyaluronic acid-chondroitin sulphate based bioadhesive formulation. 56
Exploring the genetic diversity of the 16S rRNA gene of Akkermansia muciniphila in IBD and IBS 54
Ultrasonographic assessment of gallbladder bile exchanges in healthy subjects and in gallstone patients 54
A survey of pharmacological and nonpharmacological treatment of functional gastrointestinal disorders 54
ULTRASONOGRAPHIC ASSESSMNENT OF GALLBLADDER BILE EXCHANGES IN HEALTHY SUBJECTS AND IN GALLSTONES PATIENTS 54
Bloating is associated with worse quality of life, treatment satisfaction, and treatment responsiveness among patients with constipation-predominant irritable bowel syndrome and functional constipation 54
Adalimumab in active ulcerative colitis: A "real-life" observational study 54
Intra-bolus pressure and esophagogastric gradient, assessed with high-resolution manometry, are associated with acid exposure and proximal migration of refluxate 53
Baseline impedance levels and structural and functional integrity of the esophageal mucosa: is acid still the only player? 53
Endoscopic implantation of a biopolymer in the lower esophageal sphincter for gastroesophageal reflux: a pilot study 53
Protective Effects of Grape Seed Extract on Lipopolysaccharide Exposure and Radiation-Induced Intestinal Mucosal Damage: Insights from an In Vitro Study 52
Fecal and Mucosal Microbiota Profiling in Irritable Bowel Syndrome and Inflammatory Bowel Disease 52
Increased TRPV1 gene expression in esophageal mucosa of patients with non-erosive and erosive reflux disease 52
Early-onset versus late-onset Crohn's disease: An Italian cohort study 52
Gastrointestinal neuromuscular apparatus: an underestimated target of gut microbiota 52
Normal values and regional differences in oesophageal impedance-pH metrics: a consensus analysis of impedance-pH studies from around the world 52
ULTRASONOGRAPHIC ASSESSMENT OF GALLBLADDER (GB) BILE TURNOVER BEST INDICATES THE DEFECTIVE GB EFFICIENCY IN GALLSTONES PATIENTS 52
High fat consumption in children with celiac disease 51
Associations between the IGF system and inflammatory markers in inflammatory bowel disease 51
Totale 10.643
Categoria #
all - tutte 98.867
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 98.867


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022273 0 0 4 9 3 4 0 9 6 5 1 232
2022/2023101 10 0 3 8 3 1 1 5 2 0 67 1
2023/2024836 30 77 69 55 75 350 9 62 5 55 31 18
2024/20256.676 83 71 259 46 112 159 117 22 541 437 2.142 2.687
2025/20265.875 580 342 280 592 249 310 1.706 410 496 535 191 184
2026/2027632 114 518 0 0 0 0 0 0 0 0 0 0
Totale 14.393